| |
|
|
|
Pluristem Therapeutics Inc.  
|
|
8.3043 -0.306 (-0.04%) |
07-14 14:56 |
|
Open: |
8.61 |
Pre close: |
8.61 |
Target:
|
10.92
|
|
High: |
8.7223 |
Low: |
8.29 |
Resistance:
|
9.35
10.92
|
|
Volume: |
282,321 |
Market Cap: |
207M |
Support:
|
7.81
6.85
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.67
 |
MACD |
MACD(12,26):
|
0.17 |
|
MA(20): |
8.40  |
Signal(12,26,9): |
0.18 |
|
MA(100): |
6.91 |
Stochastic Oscillator |
%K(14,3):
|
56.38 |
|
MA(250): |
5.12 |
%D(3): |
66.85 |
|
Average Volume(K) |
3-Month: |
130165
|
52-Week |
High:
|
13.29 |
|
10-Days: |
31976 |
Low: |
2.82 |
|
RSI |
RSI(14):
|
48.81 |
Change(%): |
36.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.800 |
Return on Equity (ttm) |
-252.5 |
Shares Out. (M) |
24.91 |
|
EPS Est. Current Year |
-0.350 |
Return on Assets (ttm) |
-86.5 |
Shares Float (M) |
20.27 |
|
EPS Est. Next Year |
-0.340 |
PEG Ratio |
0.00 |
% Held by Insiders |
12.15 |
|
EPS Est. Next Quarter |
-0.090 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
7.67 |
|
Forward EPS |
-2.900 |
Gross Profit (p.s.) |
0.002 |
Shares Short (K) |
1220 |
|
Book Value (p.s.) |
0.760 |
EBITDA (p.s.) |
-1.092 |
P/E |
-4.63 |
|
Sales Per Share |
0.001 |
Qtrly Earnings Growth |
0.00 |
P/BV |
10.97 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-26.72 |
P/S |
9032.58 |
|
Operating Margin |
-125621.74 |
Levered Free Cash Flow
(M) |
-15.79 |
P/CF |
-7.78 |
|
|
|
|
|
|
